Skip to main content
Top
Published in: BMC Cancer 1/2007

Open Access 01-12-2007 | Research article

pO polarography, contrast enhanced color duplex sonography (CDS), [18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography: validated methods for the evaluation of therapy-relevant tumor oxygenation or only bricks in the puzzle of tumor hypoxia?

Authors: Bernd Gagel, Marc Piroth, Michael Pinkawa, Patrick Reinartz, Michael Zimny, Hans J Kaiser, Sven Stanzel, Branka Asadpour, Cengiz Demirel, Kurt Hamacher, Heinz H Coenen, Thomas Scholbach, Payam Maneschi, Ercole DiMartino, Michael J Eble

Published in: BMC Cancer | Issue 1/2007

Login to get access

Abstract

Background

The present study was conducted to analyze the value of ([18F] fluoromisonidazole (FMISO) and [18F]-2-fluoro-2'-deoxyglucose (FDG) PET as well as color pixel density (CPD) and tumor perfusion (TP) assessed by color duplex sonography (CDS) for determination of therapeutic relevant hypoxia. As a standard for measuring tissue oxygenation in human tumors, the invasive, computerized polarographic needle electrode system (pO2 histography) was used for comparing the different non invasive measurements.

Methods

Until now a total of 38 Patients with malignancies of the head and neck were examined. Tumor tissue pO2 was measured using a pO2-histograph. The needle electrode was placed CT-controlled in the tumor without general or local anesthesia. To assess the biological and clinical relevance of oxygenation measurement, the relative frequency of pO2 readings, with values ≤ 2.5, ≤ 5.0 and ≤ 10.0 mmHg, as well as mean and median pO2 were stated. FMISO PET consisted of one static scan of the relevant region, performed 120 min after intravenous administration. FMISO tumor to muscle ratios (FMISOT/M) and tumor to blood ratios (FMISOT/B) were calculated. FDG PET of the lymph node metastases was performed 71 ± 17 min after intravenous administration. To visualize as many vessels as possible by CDS, a contrast enhancer (Levovist®, Schering Corp., Germany) was administered. Color pixel density (CPD) was defined as the ratio of colored to grey pixels in a region of interest. From CDS signals two parameters were extracted: color hue – defining velocity (v) and color area – defining perfused area (A). Signal intensity as a measure of tissue perfusion (TP) was quantified as follows: TP = vmean × Amean.

Results

In order to investigate the degree of linear association, we calculated the Pearson correlation coefficient. Slight (|r| > 0.4) to moderate (|r| > 0.6) correlation was found between the parameters of pO2 polarography (pO2 readings with values ≤ 2.5, ≤ 5.0 and ≤ 10.0 mmHg, as well as median pO2), CPD and FMISOT/M. Only a slight correlation between TP and the fraction of pO2 values ≤ 10.0 mmHg, median and mean pO2 could be detected. After exclusion of four outliers the absolute values of the Pearson correlation coefficients increased clearly. There was no relevant association between mean or maximum FDG uptake and the different polarographic- as well as the CDS parameters.

Conclusion

CDS and FMISO PET represent different approaches for estimation of therapy relevant tumor hypoxia. Each of these approaches is methodologically limited, making evaluation of clinical potential in prospective studies necessary.
Appendix
Available only for authorised users
Literature
1.
go back to reference Chapman JD, Engelhardt EL, Stobbe CC, Schneider RF, Hanks GE: Measuring hypoxia and predicting tumor radio resistance with nuclear medicine assays. Radiother Oncol. 1998, 46: 229-237. 10.1016/S0167-8140(97)00186-2.CrossRefPubMed Chapman JD, Engelhardt EL, Stobbe CC, Schneider RF, Hanks GE: Measuring hypoxia and predicting tumor radio resistance with nuclear medicine assays. Radiother Oncol. 1998, 46: 229-237. 10.1016/S0167-8140(97)00186-2.CrossRefPubMed
2.
go back to reference Clavo AC, Brown RS, Wahl RL: Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia. J Nucl Med. 1995, 36: 1625-1632.PubMed Clavo AC, Brown RS, Wahl RL: Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia. J Nucl Med. 1995, 36: 1625-1632.PubMed
3.
go back to reference Di Martino E, Gagel B, Schramm O, Maneschi P, Westhofen M: Evaluation of tumor oxygenation by color duplex sonography: A new approach. Otolaryngol Head Neck Surg. 2005, 132: 765-769. 10.1016/j.otohns.2005.01.033.CrossRefPubMed Di Martino E, Gagel B, Schramm O, Maneschi P, Westhofen M: Evaluation of tumor oxygenation by color duplex sonography: A new approach. Otolaryngol Head Neck Surg. 2005, 132: 765-769. 10.1016/j.otohns.2005.01.033.CrossRefPubMed
4.
go back to reference Eriksen JG, Horsman MR: Tumor hypoxia – a characteristic feature with a complex molecular background. Radiother Oncol. 2006, 81: 119-121. 10.1016/j.radonc.2006.09.005.CrossRefPubMed Eriksen JG, Horsman MR: Tumor hypoxia – a characteristic feature with a complex molecular background. Radiother Oncol. 2006, 81: 119-121. 10.1016/j.radonc.2006.09.005.CrossRefPubMed
5.
go back to reference Evans NTS, Naylor PFD: The effect of oxygen breathing and radiotherapy upon tissue oxygen tension of some human tumors. Br J Radiol. 1963, 36: 418-425.CrossRef Evans NTS, Naylor PFD: The effect of oxygen breathing and radiotherapy upon tissue oxygen tension of some human tumors. Br J Radiol. 1963, 36: 418-425.CrossRef
6.
go back to reference Gagel B, DiMartino E, Schramm O, Pinkawa M, Piroth M, Demirel C, Maneschi P, Stanzel S, Asadpuor B, Westhofen M, Eble MJ: Contrast-enhanced color duplex sonography (CDS): an alternative for the evaluation of therapy-relevant tumor oxygenation?. Strahlenther Onkol. 2006, 10: 604-609. 10.1007/s00066-006-1520-1.CrossRef Gagel B, DiMartino E, Schramm O, Pinkawa M, Piroth M, Demirel C, Maneschi P, Stanzel S, Asadpuor B, Westhofen M, Eble MJ: Contrast-enhanced color duplex sonography (CDS): an alternative for the evaluation of therapy-relevant tumor oxygenation?. Strahlenther Onkol. 2006, 10: 604-609. 10.1007/s00066-006-1520-1.CrossRef
7.
go back to reference Gasparini G, Weidner N, Maluta S, Pozza F, Boracchi P, Mezzetti M, Testolin A, Bevilacqua P: Intratumoral microvessel density and p53 protein: Correlation with metastasis in head-and-neck squamous-cell carcinoma. Int J Cancer. 1993, 55: 739-744. 10.1002/ijc.2910550507.CrossRefPubMed Gasparini G, Weidner N, Maluta S, Pozza F, Boracchi P, Mezzetti M, Testolin A, Bevilacqua P: Intratumoral microvessel density and p53 protein: Correlation with metastasis in head-and-neck squamous-cell carcinoma. Int J Cancer. 1993, 55: 739-744. 10.1002/ijc.2910550507.CrossRefPubMed
8.
go back to reference Gray LH, Conger AD, Ebert M: The concentration of oxygen dissolved in tissue at the time of irradiation as a factor in radiotherapy. Br J Radiol. 1953, 26: 638-642.CrossRefPubMed Gray LH, Conger AD, Ebert M: The concentration of oxygen dissolved in tissue at the time of irradiation as a factor in radiotherapy. Br J Radiol. 1953, 26: 638-642.CrossRefPubMed
9.
go back to reference Hlatky L, Alpen EL: Two dimensional diffusion limited system for cell growth. Cell Tissue Kinet. 1985, 18: 597-611.PubMed Hlatky L, Alpen EL: Two dimensional diffusion limited system for cell growth. Cell Tissue Kinet. 1985, 18: 597-611.PubMed
10.
go back to reference Höckel M, Schleger K, Aral B, Mitze M, Schäffer U, Vaupel P: Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 1996, 56: 4509-4515.PubMed Höckel M, Schleger K, Aral B, Mitze M, Schäffer U, Vaupel P: Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 1996, 56: 4509-4515.PubMed
11.
go back to reference Horsman MR, Overgaard J: Preclinical studies on how to deal with patient intolerance to nicotinamide and carbogen. Radiother Oncol. 2004, 70: 301-309. 10.1016/j.radonc.2004.01.017.CrossRefPubMed Horsman MR, Overgaard J: Preclinical studies on how to deal with patient intolerance to nicotinamide and carbogen. Radiother Oncol. 2004, 70: 301-309. 10.1016/j.radonc.2004.01.017.CrossRefPubMed
12.
go back to reference Horsman MR, Overgaard J: The oxygen effect and tumour microenviroment. Edited by: Steel GG. 2002, Basic clinical radiobiology, Arnold, London, 58-168. Horsman MR, Overgaard J: The oxygen effect and tumour microenviroment. Edited by: Steel GG. 2002, Basic clinical radiobiology, Arnold, London, 58-168.
13.
go back to reference Horsman MR: Measurement of tumor oxygenation. Int J Radiat Oncol Biol Phys. 1998, 42: 701-704. 10.1016/S0360-3016(98)00332-0.CrossRefPubMed Horsman MR: Measurement of tumor oxygenation. Int J Radiat Oncol Biol Phys. 1998, 42: 701-704. 10.1016/S0360-3016(98)00332-0.CrossRefPubMed
14.
go back to reference Hudson HM, Larkin RS: Accelerated image reconstruction using ordered subsets of projection data. IEEE Trans Med Imaging. 1994, 13: 601-609. 10.1109/42.363108.CrossRefPubMed Hudson HM, Larkin RS: Accelerated image reconstruction using ordered subsets of projection data. IEEE Trans Med Imaging. 1994, 13: 601-609. 10.1109/42.363108.CrossRefPubMed
15.
go back to reference Kallinowski F, Brownell AL, Vaupel P, Brownell GL: Combined tissue oxygen tension measurement and positron emission tomography studies on glucose utilization in oncogene-transformed cell line tumour xenografts in nude mice. Br J Radiol. 1991, 64: 350-359.CrossRefPubMed Kallinowski F, Brownell AL, Vaupel P, Brownell GL: Combined tissue oxygen tension measurement and positron emission tomography studies on glucose utilization in oncogene-transformed cell line tumour xenografts in nude mice. Br J Radiol. 1991, 64: 350-359.CrossRefPubMed
16.
go back to reference Kubota K, Tada M, Yamada S, Hori K, Saito S, Iwata R, Sato K, Fukuda H, Ido T: Comparison of the distribution of fluorine-18 fluoromisonidazole, deoxyglucose and methionine in tumour tissue. Eur J Nucl Med. 1999, 26: 750-757. 10.1007/s002590050446.CrossRefPubMed Kubota K, Tada M, Yamada S, Hori K, Saito S, Iwata R, Sato K, Fukuda H, Ido T: Comparison of the distribution of fluorine-18 fluoromisonidazole, deoxyglucose and methionine in tumour tissue. Eur J Nucl Med. 1999, 26: 750-757. 10.1007/s002590050446.CrossRefPubMed
17.
go back to reference Lehtiö K, Eskola O, Viljanan T, Oikonen V, Grönroos T, Sillanmäki L, Grenman R, Minn H: Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2004, 59: 971-982. 10.1016/j.ijrobp.2003.12.014.CrossRefPubMed Lehtiö K, Eskola O, Viljanan T, Oikonen V, Grönroos T, Sillanmäki L, Grenman R, Minn H: Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2004, 59: 971-982. 10.1016/j.ijrobp.2003.12.014.CrossRefPubMed
18.
go back to reference Mathupala SP, Heese C, Pedersen PL: Glucose catabolism in cancer cells: the type II hexokinase promoter contains functionally active response elements for the tumor suppressor p53. J Biol Chem. 1997, 272: 22776-22780. 10.1074/jbc.272.36.22776.CrossRefPubMed Mathupala SP, Heese C, Pedersen PL: Glucose catabolism in cancer cells: the type II hexokinase promoter contains functionally active response elements for the tumor suppressor p53. J Biol Chem. 1997, 272: 22776-22780. 10.1074/jbc.272.36.22776.CrossRefPubMed
19.
go back to reference Mathupala SP, Rempel A, Pedersen PL: Glucose catabolism in cancer cells. Isolation, sequence, and activity of the promoter for type II hexokinase. J Biol Chem. 1995, 270: 16918-19925. 10.1074/jbc.270.28.16918.CrossRefPubMed Mathupala SP, Rempel A, Pedersen PL: Glucose catabolism in cancer cells. Isolation, sequence, and activity of the promoter for type II hexokinase. J Biol Chem. 1995, 270: 16918-19925. 10.1074/jbc.270.28.16918.CrossRefPubMed
20.
go back to reference Miles KA, Griffiths MR, Fuentes MA: Standardized perfusion value: universal CT contrast enhancement scale that correlates with FDG PET in lung nodules. Radiology. 2001, 220: 548-553.CrossRefPubMed Miles KA, Griffiths MR, Fuentes MA: Standardized perfusion value: universal CT contrast enhancement scale that correlates with FDG PET in lung nodules. Radiology. 2001, 220: 548-553.CrossRefPubMed
21.
go back to reference Minn H, Clavo AC, Wahl RL: Influence of hypoxia on tracer accumulation in squamous-cell carcinoma: in vitro evaluation for PET imaging. Nucl Med Biol. 1996, 23: 941-946. 10.1016/S0969-8051(96)00134-5.CrossRefPubMed Minn H, Clavo AC, Wahl RL: Influence of hypoxia on tracer accumulation in squamous-cell carcinoma: in vitro evaluation for PET imaging. Nucl Med Biol. 1996, 23: 941-946. 10.1016/S0969-8051(96)00134-5.CrossRefPubMed
22.
go back to reference Nordsmark M, Bentzen SM, Rudat V, Brizel D, Lartigau E, Stadler P, Becker A, Adam M, Molls M, Dunst J, Terris DJ, Overgaard J: Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiother Oncol. 2005, 77: 18-24. 10.1016/j.radonc.2005.06.038.CrossRefPubMed Nordsmark M, Bentzen SM, Rudat V, Brizel D, Lartigau E, Stadler P, Becker A, Adam M, Molls M, Dunst J, Terris DJ, Overgaard J: Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiother Oncol. 2005, 77: 18-24. 10.1016/j.radonc.2005.06.038.CrossRefPubMed
23.
go back to reference Nunn A, Linder K, Strauss HW: Nitroimidazoles and imaging hypoxia. Eur J Nucl Med. 1995, 22: 265-280. 10.1007/BF01081524.CrossRefPubMed Nunn A, Linder K, Strauss HW: Nitroimidazoles and imaging hypoxia. Eur J Nucl Med. 1995, 22: 265-280. 10.1007/BF01081524.CrossRefPubMed
24.
go back to reference Piert M, Machulla H-J, Picchio M, Reischl G, Ziegler S, Kumar P, Wester H-J, Beck R, McEwan AJB, Wiebe LI, Schwaiger M: Hypoxia-specific tumor imaging with 18F-Fluoroazomycin Arabinoside. J Nucl Med. 2005, 46: 106-113.PubMed Piert M, Machulla H-J, Picchio M, Reischl G, Ziegler S, Kumar P, Wester H-J, Beck R, McEwan AJB, Wiebe LI, Schwaiger M: Hypoxia-specific tumor imaging with 18F-Fluoroazomycin Arabinoside. J Nucl Med. 2005, 46: 106-113.PubMed
25.
go back to reference Raleigh JA: Hypoxia and its clinical significance. Edited by: Tepper JE, Raleigh JA. Seminars in radiation oncology, Saunders, Orlando, Flo, 6: 1-70. Raleigh JA: Hypoxia and its clinical significance. Edited by: Tepper JE, Raleigh JA. Seminars in radiation oncology, Saunders, Orlando, Flo, 6: 1-70.
26.
go back to reference Sauer G, Weber KJ, Eble MJ: Comet-Assay Measurement of hypoxia correlates with preiradiation micro-electrode histography in R3327-AT rodent tumors. Radiat Res. 2000, 154 (4): 439-446. 10.1667/0033-7587(2000)154[0439:MOHUTC]2.0.CO;2.CrossRefPubMed Sauer G, Weber KJ, Eble MJ: Comet-Assay Measurement of hypoxia correlates with preiradiation micro-electrode histography in R3327-AT rodent tumors. Radiat Res. 2000, 154 (4): 439-446. 10.1667/0033-7587(2000)154[0439:MOHUTC]2.0.CO;2.CrossRefPubMed
27.
go back to reference Scholbach T, Scholbach J, Krombach GA, Gagel B, Maneschi P, DiMartino E: New method of color Doppler signal quantification in metastatic lymph nodes compared to direct polarographic measurement of tissue oxygenation. Int J Cancer. 2005, 114: 957-962. 10.1002/ijc.20827.CrossRefPubMed Scholbach T, Scholbach J, Krombach GA, Gagel B, Maneschi P, DiMartino E: New method of color Doppler signal quantification in metastatic lymph nodes compared to direct polarographic measurement of tissue oxygenation. Int J Cancer. 2005, 114: 957-962. 10.1002/ijc.20827.CrossRefPubMed
28.
go back to reference Stone HB, Brown JM, Philips TL, Sutherland RM: Oxygen in human tumors: correlations between methods of measurements and response to therapy. Radiat Res. 1993, 136: 422-434. 10.2307/3578556.CrossRefPubMed Stone HB, Brown JM, Philips TL, Sutherland RM: Oxygen in human tumors: correlations between methods of measurements and response to therapy. Radiat Res. 1993, 136: 422-434. 10.2307/3578556.CrossRefPubMed
29.
go back to reference Sorensen M, Horsman MR, Cumming P, Munk OL, Keiding S: Effect of intratumoral heterogeinity in oxygenation status on FMISO PET, autoradiography, and electrode pO2 measurements in murine tumors. Int J Radiat Oncol Biol Phys. 2005, 62: 854-861. 10.1016/j.ijrobp.2005.02.044.CrossRefPubMed Sorensen M, Horsman MR, Cumming P, Munk OL, Keiding S: Effect of intratumoral heterogeinity in oxygenation status on FMISO PET, autoradiography, and electrode pO2 measurements in murine tumors. Int J Radiat Oncol Biol Phys. 2005, 62: 854-861. 10.1016/j.ijrobp.2005.02.044.CrossRefPubMed
30.
go back to reference Thews O, Vaupel P: Relevant parameters for describing the oxygenation status of solid tumours. Strahlenther Onkol. 1996, 172: 239-242.PubMed Thews O, Vaupel P: Relevant parameters for describing the oxygenation status of solid tumours. Strahlenther Onkol. 1996, 172: 239-242.PubMed
31.
go back to reference Vaupel P: The role of hypoxia-induced factors in tumor progression. The Oncologist. 2004, 9 (Suppl 5): 10-17. 10.1634/theoncologist.9-90005-10.CrossRefPubMed Vaupel P: The role of hypoxia-induced factors in tumor progression. The Oncologist. 2004, 9 (Suppl 5): 10-17. 10.1634/theoncologist.9-90005-10.CrossRefPubMed
32.
go back to reference Vermeulen PB, Roland L, Mertens V, Van Marck E, De Bruijn EA, Van Oosterom AT, Dirix LY: Correlation of intratumoral mivrovessel density and p53 protein overexpression in human colorectal adenocarcinoma. Microvasc Res. 1996, 51: 164-174. 10.1006/mvre.1996.0018.CrossRefPubMed Vermeulen PB, Roland L, Mertens V, Van Marck E, De Bruijn EA, Van Oosterom AT, Dirix LY: Correlation of intratumoral mivrovessel density and p53 protein overexpression in human colorectal adenocarcinoma. Microvasc Res. 1996, 51: 164-174. 10.1006/mvre.1996.0018.CrossRefPubMed
33.
go back to reference Zhao S, Kuge Y, Mochizuki T, Takahashi T, Nakada K, Sato M, Takei T, Tamaki N: Biologic correlates of intratumoral heterogeneity in 18F-FDG distribution with regional expression of glucose transporters and hexokinase-II in experimental tumor. J Nucl Med. 2005, 46: 675-682.PubMed Zhao S, Kuge Y, Mochizuki T, Takahashi T, Nakada K, Sato M, Takei T, Tamaki N: Biologic correlates of intratumoral heterogeneity in 18F-FDG distribution with regional expression of glucose transporters and hexokinase-II in experimental tumor. J Nucl Med. 2005, 46: 675-682.PubMed
34.
go back to reference Zimny M, Gagel B, DiMartino E, Hamacher K, Coenen HH, Westhofen M, Eble MJ, Buell U, Reinartz P: FDG – a marker of tumour hypoxia? A comparison with [18F]-Fluoromisonidazole and pO2-Polarography in metastatic head and neck cancer. Eur J Nucl Med Mol Imaging. 2006, 33: 1426-1431. 10.1007/s00259-006-0175-6.CrossRefPubMed Zimny M, Gagel B, DiMartino E, Hamacher K, Coenen HH, Westhofen M, Eble MJ, Buell U, Reinartz P: FDG – a marker of tumour hypoxia? A comparison with [18F]-Fluoromisonidazole and pO2-Polarography in metastatic head and neck cancer. Eur J Nucl Med Mol Imaging. 2006, 33: 1426-1431. 10.1007/s00259-006-0175-6.CrossRefPubMed
Metadata
Title
pO polarography, contrast enhanced color duplex sonography (CDS), [18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography: validated methods for the evaluation of therapy-relevant tumor oxygenation or only bricks in the puzzle of tumor hypoxia?
Authors
Bernd Gagel
Marc Piroth
Michael Pinkawa
Patrick Reinartz
Michael Zimny
Hans J Kaiser
Sven Stanzel
Branka Asadpour
Cengiz Demirel
Kurt Hamacher
Heinz H Coenen
Thomas Scholbach
Payam Maneschi
Ercole DiMartino
Michael J Eble
Publication date
01-12-2007
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2007
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-7-113

Other articles of this Issue 1/2007

BMC Cancer 1/2007 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine